Lista de obras - Shirley Eberly - Dominio Público Uruguay

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis

artículo científico publicado en 2004

A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease

artículo científico publicado en 2017

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts

artículo científico

A longitudinal program for biomarker development in Parkinson's disease: a feasibility study

artículo científico publicado en 2009

A study of chorea after tetrabenazine withdrawal in patients with Huntington disease

artículo científico publicado en 2008

Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease

artículo científico publicado en 2015

Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction

scientific article published on 01 July 2005

Author Response

Caffeine consumption and risk of dyskinesia in CALM-PD.

artículo científico publicado en 2013

Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS ⬇️

artículo científico publicado el 26 de abril de 2013

Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up

artículo científico publicado en 2020

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials

artículo científico publicado en 2015

Cognition and the course of prodromal Parkinson's disease.

artículo científico publicado en 2017

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

artículo científico publicado en 2015

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study

artículo científico publicado en 2020

Comparison of posthospital survival after acute myocardial infarction in women and men

artículo científico publicado en 1994

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort

artículo científico publicado en 2017

Cumulative burden of atherosclerotic risk genotypes and the age at onset of a first myocardial infarction: a case-only carriership approach.

artículo científico publicado en 2008

Design and analysis of two-period studies of potentially disease-modifying treatments

artículo científico publicado en 2002

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

artículo científico publicado en 2015

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants

artículo científico publicado en 2009

Differences in the Presentation and Progression of Parkinson's Disease by Sex

artículo científico publicado en 2020

Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease

artículo científico publicado en 2012

Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease

artículo científico publicado en 2015

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial

artículo científico

Effect of long-term diltiazem administration on serum lipids in post-myocardial infarction survivors. Multicenter Diltiazem Post-Infarction Trial Research Group

scientific article published on 01 March 1994

Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group

artículo científico publicado en 1991

Environmental lead exposure during early childhood

artículo científico publicado en 2002

Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).

artículo científico publicado en 2016

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts

artículo científico publicado en 2019

Genome-wide variant by serum urate interaction in Parkinson's disease.

artículo científico publicado en 2015

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

scientific article published on 10 September 2019

HTRF analysis of soluble huntingtin in PHAROS PBMCs ⬇️

artículo científico publicado el 21 de agosto de 2013

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study

artículo científico publicado en 2014

Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trial

artículo científico publicado en 2014

Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.

artículo científico publicado en 2012

Improving clinical practice guidelines for practicing cardiologists

artículo científico publicado en 2015

Informativeness of Early Huntington Disease Signs about Gene Status.

artículo científico publicado en 2015

Living alone after myocardial infarction. Impact on prognosis

artículo científico publicado en 1992

Long-term palliation with the classic Blalock-Taussig shunt.

artículo científico publicado en 1988

Longitudinal follow-up of SWEDD subjects in the PRECEPT Study

artículo científico publicado en 2014

Mendelian randomization of serum urate and parkinson disease progression

artículo científico publicado en 2014

Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments

artículo científico publicado en 2013

Parental responses to infant crying and colic: the effect on breastfeeding duration

scientific article published on 01 January 2006

Phenotype-genotype discrepancies in the prospective Huntington at-risk observational study

scientific article published on 01 May 2019

Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson's disease: the SPIN-PD study

artículo científico publicado en 2015

Polymorphism in the angiotensinogen gene, hypertension, and ethnic differences in the risk of recurrent coronary events

artículo científico publicado en 2006

Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers

artículo científico publicado en 2007

Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction

artículo científico publicado en 2007

Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts

artículo científico

Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients

artículo científico publicado en 2002

Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeeding

scientific article published on 01 March 2003

Rasagiline improves quality of life in patients with early Parkinson's disease

artículo científico publicado en 2006

Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms

artículo científico publicado en 2006

Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease

article by Karen Marder et al published November 2013 in JAMA Neurology

Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes"

artículo científico publicado en 2018

Reply: Unusual DAT scan results

artículo científico publicado en 2013

Reproducibility of data-driven Parkinson's disease subtypes for clinical research

artículo científico publicado en 2018

Risk Factors for Suicidal Ideation in People at Risk for Huntington's Disease

artículo científico publicado en 2016

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea

artículo científico publicado en 2017

Safety of rasagiline in elderly patients with Parkinson disease

artículo científico publicado en 2006

Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease

artículo científico publicado en 2018

Senior Academic Physicians and Retirement Considerations ⬇️

artículo científico publicado el 21 de marzo de 2013

Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.

artículo científico publicado en 2011

Serum urate and probability of dopaminergic deficit in early "Parkinson's disease".

artículo científico publicado en 2011

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's

scientific article published on 22 September 2016

The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation

artículo científico publicado en 2019

The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study

scientific article published on 15 May 2019

Urate as a predictor of the rate of clinical decline in Parkinson disease

artículo científico publicado en 2009

Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study

artículo científico publicado en 2011

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

artículo científico publicado en 2001

Lista de obras de Shirley Eberly

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis

A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts

A longitudinal program for biomarker development in Parkinson's disease: a feasibility study

A study of chorea after tetrabenazine withdrawal in patients with Huntington disease

Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease

Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction

Author Response

Caffeine consumption and risk of dyskinesia in CALM-PD.

Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS ⬇️

Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials

Cognition and the course of prodromal Parkinson's disease.

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study

Comparison of posthospital survival after acute myocardial infarction in women and men

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort

Cumulative burden of atherosclerotic risk genotypes and the age at onset of a first myocardial infarction: a case-only carriership approach.

Design and analysis of two-period studies of potentially disease-modifying treatments

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants

Differences in the Presentation and Progression of Parkinson's Disease by Sex

Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease

Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial

Effect of long-term diltiazem administration on serum lipids in post-myocardial infarction survivors. Multicenter Diltiazem Post-Infarction Trial Research Group

Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group

Environmental lead exposure during early childhood

Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts

Genome-wide variant by serum urate interaction in Parkinson's disease.

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

HTRF analysis of soluble huntingtin in PHAROS PBMCs ⬇️

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study

Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trial

Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.

Improving clinical practice guidelines for practicing cardiologists

Informativeness of Early Huntington Disease Signs about Gene Status.

Living alone after myocardial infarction. Impact on prognosis

Long-term palliation with the classic Blalock-Taussig shunt.

Longitudinal follow-up of SWEDD subjects in the PRECEPT Study

Mendelian randomization of serum urate and parkinson disease progression

Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments

Parental responses to infant crying and colic: the effect on breastfeeding duration

Phenotype-genotype discrepancies in the prospective Huntington at-risk observational study

Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson's disease: the SPIN-PD study

Polymorphism in the angiotensinogen gene, hypertension, and ethnic differences in the risk of recurrent coronary events

Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers

Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction

Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts

Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients

Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeeding

Rasagiline improves quality of life in patients with early Parkinson's disease

Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms

Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease

Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes"

Reply: Unusual DAT scan results

Reproducibility of data-driven Parkinson's disease subtypes for clinical research

Risk Factors for Suicidal Ideation in People at Risk for Huntington's Disease

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea

Safety of rasagiline in elderly patients with Parkinson disease

Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease

Senior Academic Physicians and Retirement Considerations ⬇️

Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.

Serum urate and probability of dopaminergic deficit in early "Parkinson's disease".

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's

The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation

The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study

Urate as a predictor of the rate of clinical decline in Parkinson disease

Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression